Allogene Therapeutics ALLO incurred a loss of 28 cents per share in fourth-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of 34 cents. In the year-ago period, the company had ...

CHPT's fourth-quarter fiscal 2025 results reflect a year-over-year decrease in loss, improved margins and cost cuts despite a ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks ...

AST SpaceMobile, Inc. (ASTS) shares declined in Tuesday’s premarket trading after the satellite communications-equipment ...

Olaplex Holdings shares were 16% higher at $1.60 each, after the company reported a narrower-than-expected fourth-quarter loss, and better-than-expected sales.

Lemonade, Inc. LMND reported a fourth-quarter 2024 operating loss of 42 cents per share, narrower than the Zacks Consensus Estimate of a loss of 60 cents as well as the year-ago loss of 61 cents ...